Navegar por los elementos (1475 total)

• 

  Appropriate selection of convalescent plasma donors for COVID-19

  Etiquetas 2019-nCoV, Coronavirus, COVID-19, R-Lab, R-Res&Pub, Therapeutics
  Autor: Tedder, Richard S., and Malcolm G. Semple.
  Tema: Laboratory
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-06-15
  Descripción: We read with considerable interest the Comment from Long Chen and colleagues about the potential use of convalescent plasma for the treatment of COVID-19.

• De-isolating COVID-19 Suspect Cases: A Continuing Challenge

  Etiquetas 2019-nCoV, Coronavirus, COVID-19, Infection Prevention and Control, Isolate, Isolation/Biocontainment, R-IPC, R-Res&Pub, Treatment and Care
  Autor: Tay, Jun-Yang, Poh Lian Lim, Kalisvar Marimuthu, Sapna Pradip Sadarangani, Li Min Ling, Brenda Sze Peng Ang, Monica Chan, Yee-Sin Leo, and Shawn Vasoo.
  Tema: Infection Control
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-02-26
  Descripción: To the Editor—As of 15 February 2020, Singapore had screened a total of 991 suspected cases for coronavirus disease 2019 (COVID-19), of which 72 cases tested positive, 812 cases tested negative, and the remaining 107 had pending results.

• Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

  Etiquetas Ebola, Pediatrics, R-Res&Pub, R-SP, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Autor: Tapia, Milagritos D., Samba O. Sow, Khardiata D. Mbaye, Aliou Thiongane, Birahim P. Ndiaye, Cheikh T. Ndour, Souleymane Mboup, Babajide Keshinro, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche, Kwadwo A. Koram, Kwaku P. Asante,…
  Tema: Research
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-03-19
  Descripción: During the large 2013–16 Ebola virus outbreak caused by the Zaire Ebola virus, about 20% of cases were reported in children. This study is the first, to our knowledge, to evaluate an Ebola vaccine in children younger than 6 years.

• Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

  Etiquetas Ebola, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Autor: Tapia, Milagritos D., Samba O. Sow, Birahim P. Ndiaye, Khardiata D. Mbaye, Aliou Thiongane, Cheikh T. Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Gideon A. Akintunde, Thompson N. Kinge, Guy Vernet, Jean Joel Bigna, Stephen Oguche,…
  Tema: Research
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-03-19
  Descripción: The 2014 Zaire Ebola virus disease epidemic accelerated vaccine development for the virus.
• 

  Different types of door-opening motions as contributing factors to containment failures in hospital isolation rooms

  Etiquetas Coronavirus, Flu, Infection Prevention and Control, Influenza, Isolate, Isolation/Biocontainment, Occupational Exposure, Physical Infrastructure, R-PhIn, R-Res&Pub, SARS, Staff Support, Staffing
  Autor: Tang, Julian W., Andre Nicolle, Jovan Pantelic, Christian A. Klettner, Ruikun Su, Petri Kalliomaki, Pekka Saarinen, Hannu Koskela, Kari Reijula, Panu Mustakallio, David K. W. Cheong, Chandra Sekhar, and Kwok Wai Tham.
  Tema: Infection Control
  Tipo de elemento: Publicación
  Fecha de actualización: 2013-06-24
  Descripción: Hospital isolation rooms are vital for the containment (when under negative pressure) of patients with, or the protection (when under positive pressure) of patients, from airborne infectious agents.

• Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis

  Etiquetas 2019-nCoV, Clinical Care, Coronavirus, COVID-19, R-Res&Pub, R-T&C
  Autor: Tabata, Sakiko, Kazuo Imai, Shuichi Kawano, Mayu Ikeda, Tatsuya Kodama, Kazuyasu Miyoshi, Hirofumi Obinata, Satoshi Mimura, Tsutomu Kodera, Manabu Kitagaki, Michiya Sato, Satoshi Suzuki, Toshimitsu Ito, Yasuhide Uwabe, and Kaku Tamura.
  Tema: Treatment & Care
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-06-12
  Descripción: The ongoing COVID-19 pandemic is a global threat. Identification of markers for symptom onset and disease progression is a pressing issue. We described the clinical features of people infected on board the Diamond Princess cruise ship who were…

• A detailed instructional process for donning and doffing level C personal protective equipment in a healthcare setting

  Etiquetas Donning and Doffing, Personal Protective Equipment (PPE), R-PPE
  Autor: Swanhorst, J., K. Boulter, A. Vasa, B. Boeckman and M. Schwedhelm
  Tema: Training and Exercises
  Tipo de elemento: Publicación
  Fecha de actualización: 2014-06-09
  Descripción: Use of Level C personal protective equipment is an uncommon practice in the routine provision of nursing care.

• Universal Screening for SARS-CoV-2 in Women Admitted for Delivery

  Etiquetas 2019-nCoV, Coronavirus, COVID-19, Labor and Delivery, Laboratory Testing, Not updated, R-Res&Pub, R-SP, R-T&C
  Autor: Sutton, Desmond, Karin Fuchs, Mary D’Alton, and Dena Goffman.
  Tema: Treatment & Care
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-04-13
  Descripción: In recent weeks, Covid-19 has rapidly spread throughout New York City. The obstetrical population presents a unique challenge during this pandemic, since these patients have multiple interactions with the health care system and eventually most are…

• Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

  Etiquetas 2019-nCoV, Coronavirus, COVID-19, Immunology, Lab, Laboratory, R-Res&Pub, Research
  Autor: Suthar, Mehul S., Matthew G. Zimmerman, Robert C. Kauffman, Grace Mantus, Susanne L. Linderman, William H. Hudson, Abigail Vanderheiden, Lindsay Nyhoff, Carl W. Davis, Oluwaseyi Adekunle, Maurizio Affer, Melanie Sherman, Stacian Reynolds, Hans P.…
  Tema: Research
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-06-23
  Descripción: SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection.

• Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

  Etiquetas 2019-nCoV, Antibodies, Coronavirus, COVID-19, Immunology, Laboratory Testing, R-Lab, R-Res&Pub, Research, SARS-CoV-2
  Autor: Suthar, M. S., M. G. Zimmerman, R. C. Kauffman, G. Mantus, S. L. Linderman, W. H. Hudson, A. Vanderheiden, L. Nyhoff, C. W. Davis, O. Adekunle, M. Affer, M. Sherman, S. Reynolds, H. P. Verkerke, D. N. Alter, J. Guarner, J. Bryksin, M. C. Horwath, C.…
  Tema: Laboratory
  Tipo de elemento: Publicación
  Fecha de actualización: 2020-06-23
  Descripción: SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection. We…